findmyKOL
Clinical trialNCT01011972CompletedPhase 1Interventional

A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors

SponsorMersana TherapeuticsEnrollment52Neoplasm Metastasis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

XMT-1107 has been shown in nonclinical studies to slow the growth of tumors. These effects may result from blocking the growth of new blood vessels that help the tumors survive.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Md Greenbaum Cancer Center

    Baltimore, Maryland, United States

  • Beth Israel Deaconess Medical Center (bidmc)

    Boston, Massachusetts, United States

  • Dana Farber Cancer Institute (dfci)

    Boston, Massachusetts, United States

  • Sarah Cannon Research Institute (scri)

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

XMT-1107
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2010
Primary completion
30 Sept 2013
Completion
30 Sept 2013
Last update posted
31 Jan 2018
Registered enrollment
52
Registry id
NCT01011972
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.